The CD5 Coreceptor’s Effect on T Cell Proliferation in Periodontal Disease
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Preliminary Results

Introduction
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Periodontal Disease: Periodontal disease (gun disease) is a preventable yet common
oral inflammatory disease caused by prolonged exposure of the oral epithelium to
bacteria. With prolonged exposure to pathogens, inflammation begins and T cells are
recruited to the infection site. In particular, helper T cells are recruited and exacerbate
bone destruction and resorption by increasing inflammation and recruiting more
immune cells to the site of infection.
T cell Interactions: T cell function is regulated via signaling of the T cell receptor
(TCR) and co-receptors expressed on the surface of the cell, which can stimulate or
inhibit T cell function. CD5 is a T cell co-receptor that regulates T cell development and
function. Our study investigates the role of CD5 in helper T cell activation and its effect
in oral inflammation. We will compare the differences in proliferation of stimulated T
cells with and without CD5. Cell proliferation is an indication of T cell activation. If
CD5 regulates helper T cell activation it could be a target for treatments of periodontal
disease.

Conclusions and Future Directions
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To investigate the relationship helper T cell activation in response to stimuli associated
with periodontal disease

Hypothesis
We hypothesize that T cells lacking CD5 (CD5 KO) will have increased proliferation
compared to T cells expressing CD5 (CD5 WT).

Materials and Methods

Figure 1. CD5KO CD4 T cells appear to proliferate less than CD5WT CD4 T cells. A. CD5WT
CD4 T cells have more cells present in later generations showing more proliferation. Green peaks represent
the proliferation model fit to the data, which is shown on the graph as a solid black line. B. Proliferation
indexes of CD5WT and CD5KO CD4 T cells were compared with WT controls after 48 and 72 hours. The
bars for the CD5KO CD4 T cells are significantly less than the CD5WT.
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Cell lines used: Oral mucosa epithelial cells, and Gingiva epithelial cells from mice
(C57BL/6 background). Cell lines were exposed to LPS from P.gingivalis (LPS-PG) and
LPS from E.coli (LPS-EC) for 24 hrs.
Splenocytes from CD5KO and CD5WT mice (C57BL/6 background), were isolated and cocultured as follows:
1. Each of the oral epithelial cells and their supernatant for 48 and 72 hours.
2. Observed differences in T cell proliferation by comparing intensities of intracellular
staining (CFSE) using flow cytometry.
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Clinical Implications of Research
Some of the most detrimental consequences of severe periodontitis (bone and tooth
loss) result directly from the body’s immune inflammatory response to bacterial
infection in the gingiva. Our research aims to deepen our understanding of the immune
response to infection in the oral cavity.
This relevant in the dental field since an understanding in oral immunology response
could help to comprehend clinical associations between periodontal disease and
systemic diseases, which might result in the improvement of patient management, as
well as the creation of new avenues for periodontal disease treatment. Our main aim is
to understand how managing CD5 expression in the oral cavity could dampen the
body’s immune response, and mitigate the negative consequences of periodontal
disease.
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It is hard to say if our preliminary data is starting to suggest that our hypothesis is
correct because our controls have not been reliable. We have not been able to show a
clear distinction between a positive and negative control. There are certainly some
interesting trends in our data but no conclusions can be drawn without clear positive
and negative controls.
Previous studies conducted in our lab have suggested that our hypotheses are correct.
Some of our research showed significant differences between CD5 WT and CD5 KO CD4
T cells surface markers commonly associated with early and late activation (CD69 and
CD25). Because of these results we would suspect that proliferation would also be
inhibited in cells with CD5 present.
We are still in the process of optimizing this experiment and hope to have more
convincing results in the future to draw conclusions about the role of CD5 in T cell
proliferation associated with periodontal disease.

Figure 2. Positive and negative controls do not show distinct differences. A. CD4 T cells from
both CD5WT and CD5KO stimulated with CD3/28 beads showed no significant difference in proliferation
after 48 hours. Green peaks represent the proliferation model fit to the data, which is shown on the graph as
a solid black line. B. Proliferation indexes of all controls were compared at 48 and 72 hours. Columns
labeled as “direct” represent CD4 T cells stimulated with LPS from E. coli.
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